Biotech Voices

Visualize: Just how much did biotech unicorn Moderna rely on immigrants to build the staff?


Over the last few weeks we’ve been running a slide show illustrating in starkly graphic tones just how important immigrants are to biotechnology. That issue, which has become increasingly controversial as President Donald Trump has sought to redraw the rules governing immigration, clearly struck a nerve at biotech unicorn Moderna. CEO Stéphane Bancel, a native son of France, gathered with his big staff to illustrate just how many staffers had a family tree rooted in immigration — or directly connected to it. Let’s let the pictures do the talking, below.

And for the full set of biotechs who have done this, you can check it out here.


The best place to read Endpoints News? In your inbox.

Full-text daily reports for those who discover, develop, and market drugs. Join 21,000+ biopharma pros who read Endpoints News by email every day.

Free Subscription

Biomanufacturing